Our monthly Discussion Groups are hosted by a panel of leading industry experts who explore some of the key issues facing biologics therapeutics today.
Register below to receive a live stream of the discussion as well a complimentary report outlining the key findings and conclusions covered.
24 Sept 2021 | Online: 10:00 ET (UTC-4) / 15:00 BST (UTC+1)
With the recent advancements of antibody engineering technologies, techniques and methods, the market has seen an expansion. This growth is largely attributed to our better understanding of new modalities, smarter ways of choosing our targets and ensuring their quality, though challenges still remain. Our September discussion groups brings together an exclusive panel of key opinion leaders discussing the key factors behind the market’s growth, its priorities, future outlook & challenges.
Presentation: Antibody Discovery At Novo Nordisk
Speaker: Erik Vernet, Director, Antibody technology, Novo Nordisk
Panel Discussion: Oral Delivery of Biologics – Current Challenges & Opportunities
Moderator: Erik Vernet, Director, Antibody Technology, Novo Nordisk
Panellists:
Taking place October 2021
Viewer Registration Coming Soon
Taking place November 2021
Viewer Registration Coming Soon
Reports and write-ups pertaining to previous Discussion Groups are available in our Insights section.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
Submit your details to register your interest & to be kept up to date about relevant services or events. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.
Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.
